Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery-Reference-Cited by-同舟云学术

Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery

Published:2020 Issue:22 Volume:12 Page:12083-12097
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Huang Yongjia¹²³⁴,Gu Jing⁵⁶⁷⁸⁴,Yan Zijun¹²³⁴,Hu Xueyuan¹²³⁴,He Dan¹²³⁴,Zhang Yonghong¹²³⁴,Li Yao⁹¹⁰¹¹⁴,Zhong Cailing¹²³⁴,Yang Jie¹²³⁴,Shi Da¹²¹³¹⁴¹⁵,Abagyan Ruben¹²¹³¹⁴¹⁵,Tan Qunyou⁵⁶⁷⁸⁴,Zhang Jingqing¹²³⁴^ORCID

Affiliation:

1. Chongqing Research Center for Pharmaceutical Engineering

2. Chongqing Medical University

3. Chongqing 400016

4. China

5. Department of Thoracic Surgery

6. Daping Hospital of Army Medical University

7. PLA

8. Chongqing 400042

9. Division of infectious disease

10. Chongqing Public Health Medical Center

11. Chongqing 400036

12. Skaggs School of Pharmacy and Pharmaceutical Sciences

13. University of California San Diego

14. La Jolla

15. USA

Abstract

Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component were applied to effectively deliver asparaginase supramolecule.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NR/D0NR02588G

Reference55 articles.

1. Ligand‐Installed Nanocarriers toward Precision Therapy

2. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers